Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

  • Mohammad Z. Ahmed
  • , Qamar Zia
  • , Anzarul Haque
  • , Ali S. Alqahtani
  • , Omar M. Almarfadi
  • , Saeed Banawas
  • , Mohammed S. Alqahtani
  • , Keshav L. Ameta
  • , Shafiul Haque

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

29 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science